Clinical Trial Update: Irinotecan Combined With Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer : a Single Center Prospective Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating first-line irinotecan combined with cisplatin for advanced esophageal squamous cell carcinoma conducted at a single center. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Peking University | Conditions: Advanced Esophageal Squamous Carcinoma | Phase 2 | Status: UNKNOWN